Head of TA portfolio Strategy

Job Title: Head of TA portfolio Strategy

Location: Cambridge, MA

About the Job

Are you ready to shape the future of medicine? The race is on to speed up drug discovery and development to find answers for patients and their families. Your skills could be critical in helping our teams accelerate progress.

The Global R&D Strategy and Portfolio Management team’s overarching objective is to equip Sanofi’s leaders with robust, objective and externally focused insights and recommendations they need to make better informed R&D strategy, and portfolio and project investment decisions to ensure pipeline sustainability.  

We achieve this by (1) delivering a comprehensive R&D strategy positioning the organization to embrace future opportunities and challenges, driving sustained success (2) by ensuring a sustainable portfolio strategy, robust valuation and prioritization of the R&D portfolio and optimization of resources, high quality pipeline reporting, benchmarking, and scientific competitive intelligence (3) by ensuring high quality investment governance incorporating decision quality and thoughtful risk taking principles.

The Global R&D Portfolio Strategy and Management team works with key stakeholders across the organization (R&D and GBUs) to support portfolio & project decision-making aligned to our corporate strategy and agreed TA strategies.

The team’s remit is to:

•  

• Define investment governance process for R&D together with R&D senior leadership and ExCom and ensure disciplined and robust implementation for the most senior joint R&D and Commercial investment board called the IDCC.

•  Use advanced analytics to inform and shape decision making by senior leadership (e.g., stage gate analysis to determine optimal development strategy, scenario analysis, decision trees, pipeline sustainability, etc.). The Therapeutic Area (TA) Leads work with the Global Project teams (GPTs) to present these analytics at key Go/No go decisions during Governance meetings. The R&D Portfolio Strategy team ensures the consolidation of these analyses into a holistic TA and cross-TA portfolio view (pipeline volume, risk, value) with data visualization tools and makes recommendations as to optimize utilization of resources and facilitate trade-off discussion amongst senior leaders.

•  Ensure R&D asset, TA and Company pipeline valuation (including evolution of risk) are done in a continuous, rigorous, and comparable basis across Sanofi Research and Development Pharma and TA (TBC), including the development of standard tools and an effective review process. Provide challenge to cross-functions and project teams’ assumptions via quantitative analyses of previous Sanofi performance and external benchmarks, integration of internal data available and external Open-source information using artificial intelligence approaches to draw insights, and continuously identifying new sources of data that can inform quantitative analyses.

•  Ensure robust pipeline reporting and benchmarking to support the R&D and portfolio strategy and portfolio sustainability linked to the external equity story in partnership with Investor Relations.

•  Ensure robust external competitive intelligence insights to drive technology investments and asset strategy decisions.

The Portfolio Strategy & Management Team is looking to add a team-oriented member in the role of Head of TA (TBC) portfolio strategy who will play a pivotal role in shaping and driving the strategic direction for our TA (TBC) portfolio together with the GBU and R&D stakeholders. As a leader within this group, you will gain exposure to all of Sanofi’s therapy areas and come to truly understand the ‘nuts and bolts’ of the business. This position requires a seasoned leader with a deep understanding of therapeutic areas, market dynamics, and drug development processes. The successful candidate will be responsible for leading strategic initiatives, optimizing our R&D pipeline, and ensuring alignment between our research objectives and market needs.

The Head of R&am